The GLOW stack extended with KPV, the C-terminal alpha-MSH tripeptide, for research protocols that pair dermal repair with anti-inflammatory signalling.
§ 1 — Specification
CompoundKLOW
CompositionKPV · GHK-Cu · BPC-157 · TB-500
Research areaDermal
Content per vial80 mg blend
HPLC purity≥ 99% per component
Identity confirmation
Mass spectrometry, per component
Physical form
Lyophilised powder blend
Current lotBYK-2747-04
Endotoxin
Tested — report attached
§ 2 — Suggested research protocol
Reconstitute with bacteriostatic water to the working concentration required by the assay. Concentration ranges reported in the literature vary widely by model and endpoint; the figures below reflect published in-vitro and animal protocols only and are not human-use guidance.
Protocol table slot — concentration / vehicle / interval
§ 3 — Storage & reconstitution
01
Unopened vials: store at −20 °C, protected from light. Stable for 24 months from the lot date.
02
Reconstitute with bacteriostatic water down the vial wall. Do not shake; swirl until fully dissolved.
03
Reconstituted: refrigerate at 2–8 °C, use sterile access technique, protect from light.
04
Avoid repeated warming and freeze-thaw cycles — both shorten usable research life more than shelf age does.
§ 4 — References
Reference slot 01 — add citation
Reference slot 02 — add citation
Reference slot 03 — add citation
§ 5 — Reviews
Reviews slot — connect a verified-purchase review app
